Rabbit Anti-Human FLT3 (CD135) (N-term) Antibody, 400 ul
Loading...
Loading...
Loading...
Loading...
| Size | 400 µL |
| Estimated Lead Time | 1-2 weeks |
| Species | Human |
| Host Species | Rabbit |
| Accession Number | P36888 |
| Gene Id | 2322 |
| Gene Symbols | FLT3 |
| Protein Name / Synonyms | FLT3 (CD135) (N-term) |
| Clonality | Polyclonal |
| Preparation | This FLT3 (CD135) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 33-64 amino acids from the N-terminal region of human FLT3 (CD135). |
| Concentration (lot specific) | 1.200 mg/ml |
| Recommended Applications | FC, Western Blotting, IHC-P |
| Research Area | Cancer |
| Shipping Type | Blue ice |
| Storage | -20°C |
![]() | FLT3 (CD135) Antibody (N-term) (Cat# 102-17508) flow cytometric analysis of 293 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis. |
![]() | Western blot analysis of anti-FLT3 Pab (Cat# 102-17508) in HL-60 cell lysate. FLT3 (arrow) was detected using purified Pab. Secondary HRP-anti-rabbit was used for signal visualization with chemiluminescence. |
![]() | Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma. |
Your cart is empty.
Anti-FLT3 (CD135) (N-term) Antibody
Anti-FLT3 (CD135) (N-term) Antibody